Market revenue in 2023 | USD 105.1 million |
Market revenue in 2030 | USD 196.9 million |
Growth rate | 9.4% (CAGR from 2023 to 2030) |
Largest segment | Surgery |
Fastest growing segment | Intralesional injections |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Radiotherapy (RT), Intralesional injections, Intravenous Medications, Chemical peeling treatment, Surgery, Topical chemotherapy, Oral Medications |
Key market players worldwide | Bausch Health Companies Inc, Almirall SA, Genentech, Novartis AG ADR, Regeneron Pharmaceuticals Inc, Dr Reddy's Laboratories Ltd ADR, Taro Pharmaceuticals, Accord Healthcare |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to basal cell carcinoma treatment market will help companies and investors design strategic landscapes.
Surgery was the largest segment with a revenue share of 35.97% in 2023. Horizon Databook has segmented the Latin America basal cell carcinoma treatment market based on radiotherapy (rt), intralesional injections, intravenous medications, chemical peeling treatment, surgery, topical chemotherapy, oral medications covering the revenue growth of each sub-segment from 2018 to 2030.
The Latin America basal cell carcinoma treatment market has exhibited significant growth in the past few years owing to the increase in the prevalence of various types of cancer in the region. Several surveys by various government and nonprofit organizations revealed that overall cancer mortality in Latin America is almost twice that of high-income countries.
In the past few years, the region has witnessed rapid growth in cancer screening techniques, along with other cancer detection methods, owing to increasing funding & implementation of various cancer programs.
For instance, in 2019, PAHO partnered with the International Agency for Research on Cancer to implement the CanScreen5 project in Latin America and the Caribbean. However, poor infrastructure and inaccessibility to remote regions.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America basal cell carcinoma treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America basal cell carcinoma treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account